-

Wiley Acquires Bio-Rad’s Informatics Spectroscopy Software and Spectral Databases

Latest Acquisition Enhances Wiley Science Solutions Furthering Laboratory Impact

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases. The acquisition adds expertise, content, and powerful software to Wiley’s Science Solutions segment. Terms of the agreement are not disclosed.

“Laboratory-generated data is at the heart of all research. We welcome these new spectroscopy products and services that will help enhance the Wiley Science Solutions portfolio,” said Judy Verses, Executive Vice President, Wiley Research. “These software and spectral libraries are invaluable interpretation tools for researchers who are making an impact in laboratories ranging from environmental to pharmaceutical, and from aerospace to toxicology.”

As one of the largest providers of spectral libraries in mass spectrometry and long-standing partner of Wiley, Bio-Rad’s Sadtler spectra databases in IR, Raman, UV-Vis and NMR allows Wiley to expand its offering in the spectroscopy market. With the acquisition of Bio-Rad’s KnowItAll desktop spectroscopy data system (SDS), server SDS, web-server SDS and ChemWindow chemical structure drawing software, Wiley is poised to enhance its support in vital areas of research data interpretation.

Wiley Science Solutions has been a trusted partner in publishing empirical, experimental, and validated data for laboratory solutions, aiming to improve the quality of chemical analysis and identification through spectral libraries and providing researchers with high-quality data collections to reduce errors and increase productivity in analytical, environmental, food, medicinal, and toxicology laboratories.

This acquisition underscores Wiley’s commitment to investing in technology-based solutions that support the important research and development taking place in government, university and commercial labs around the world.

BIO-RAD, CHEMWINDOW, and KNOWITALL are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Contacts

Wiley Investor Relations:
Brian Campbell, +1 201 748 6874
brian.campbell@wiley.com

Media Relations:
Dawn Peters (US): +1 781 388 8408
newsroom@wiley.com
Follow us on Twitter @WileyNews

John Wiley and Sons Inc.

NYSE:WLY
Details
Headquarters: Hoboken, New Jersey
CEO: Matthew Kissner
Employees: 7,000
Organization: PUB

Release Versions

Contacts

Wiley Investor Relations:
Brian Campbell, +1 201 748 6874
brian.campbell@wiley.com

Media Relations:
Dawn Peters (US): +1 781 388 8408
newsroom@wiley.com
Follow us on Twitter @WileyNews

More News From John Wiley and Sons Inc.

Wiley Launches Its First Spectral Analysis API Portfolio, Giving Labs a Faster Path from Unknown Substance to Validated Answer

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of its spectral analysis application programming interface (API) portfolio, providing users with a new, faster way to access its trusted spectral data, analytical algorithms, and predictive models—within their own workflows. Wiley has one of the most comprehensive and trusted collections of scientific reference databases in the world, relied upon as a...

Wiley Joins U.S. Department of Energy's Genesis Mission Consortium to Advance AI-Powered Scientific Discovery

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY) today announced its membership in the Genesis Mission Consortium, the public-private partnership supporting the U.S. Department of Energy's (DOE) Genesis Mission, joining organizations including Nvidia, AWS, Microsoft, IBM, and AMD. Wiley is the only scientific publisher among the consortium's members and has been invited to demonstrate its work today at the Genesis Mission Annual Summit in Washington, D.C. The Genesis Mission is a Department of...

Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released Scientific Discovery & AI: The Science-to-Patient Journey, a cross-sector intelligence report drawing on candid dialogue among more than 25 senior leaders from pharma R&D, academic medicine, health systems, AI and technology, publishing and learned societies. The report summarizes insights from The Summit — an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. The sessi...
Back to Newsroom